Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
6
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
14 competitors in Type 2 Diabetes Mellitus
No patent data available. Pre-approval drugs may not have Orange Book listings.
Semglee
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
View on EMALusduna
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
View on EMAAbasaglar (previously Abasria)
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
View on EMALyxumia
Lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.
View on EMAToujeo (previously Optisulin)
Treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.
View on EMAInfluenza (Healthy Volunteers)
Type 2 Diabetes Mellitus
Diphtheria
Non Small Cell Lung Cancer
Influenza